Sreekanth A. Ramachandran

Author

Also Known As

Ramachandran S., Ramachandran, S.A., S. Ramachandran, Santhiya Ramachandran, Sreekanth A. Ramachandran, Sreekanth Ramachandran

Publications

329

Citations

H-Index

Concepts

All Affiliations

Fundación Ciencia and Vida GlaxoSmithKline (Spain)Pfizer (United States)AstraZeneca (India)Schrodinger (United States)

About

Sreekanth A. Ramachandran is an author at Fundación Ciencia and Vida specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	250
2	Natural Sciences	6	6	165
3	Biochemistry	4	4	109
4	Biomolecular Engineering	2	2	62
5	Engineering	1	1	38

Sreekanth A. Ramachandran

Publications

306

Citations

H-Index

Page 1

	Year	Citations
Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity Manoranjan Panda, Sreekanth A. Ramachandran, Vasanthi Ramachandran, Journal of Medicinal Chemistry Antimicrobial ChemotherapyPharmaceutical ChemistryPotent Anti-mycobacterial ActivityMtb StrainDrug Resistance	2014	93
<i>N</i>-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds Sreekanth A. Ramachandran, Shahul Hameed P, Abhishek Srivastava, Journal of Medicinal Chemistry Phenotypic ScreeningPharmaceutical ScienceAntiparasitic AgentMalariaRat Blood	2014	41
Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series Sreekanth A. Ramachandran, Manoranjan Panda, Kakoli Mukherjee, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryStructure Activity RelationshipBioorganic ChemistryEngineeringNatural Sciences	2013	38
Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents Shahul Hameed P, Murugan Chinnapattu, Gajanan Shanbag, Journal of Medicinal Chemistry Pharmaceutical ScienceAntiparasitic AgentMalariaPlasmodium FalciparumPharmaceutical Chemistry	2014	29
Synthetic Studies toward Highly Functionalized 5β-Lanosterol Derivatives: A Versatile Approach Utilizing Anionic Cycloaddition Sreekanth A. Ramachandran, Rajendra K. Kharul, Sylvain R. A. Marque, The Journal of Organic Chemistry Medicinal ChemistryBioorganic ChemistryBiochemistrySynthetic IntermediatesSynthetic Studies	2006	24
Synthetic Approach Toward the Total Synthesis of Kempane Diterpenes via Transannular Diels−Alder Strategy Franck Caussanel, Keyan Wang, Sreekanth A. Ramachandran, The Journal of Organic Chemistry	2006	18
Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors Sreekanth A. Ramachandran, Pradeep S. Jadhavar, Sandeep K. Miglani, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryDerivative (Chemistry)Natural SciencesMedicine	2017	18
Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors Pradeep S. Jadhavar, Sreekanth A. Ramachandran, Eduardo Riquelme, Bioorganic & Medicinal Chemistry Letters UrologyDrug TargetingHdac6 InhibitorsMedicineDual Activity	2016	17
Identification and Mitigation of a Reactive Metabolite Liability Associated with Aminoimidazoles Abhishek Srivastava, Sreekanth A. Ramachandran, Shahul Hameed, Chemical Research in Toxicology Rm LiabilityChemical ModificationMetabolomic ProfilingSecondary MetaboliteToxicological Mechanism	2014	15
Discovery of pyrazolopyrimidine derivatives as novel inhibitors of ataxia telangiectasia and rad3 related protein (ATR) Sreekanth A. Ramachandran, Pradeep S. Jadhavar, Manvendra Singh, Bioorganic & Medicinal Chemistry Letters Pyrazolopyrimidine DerivativesMedicineRational Drug DesignMolecular BiologyAtaxia Telangiectasia	2017	13

Page 1